Additionally, the 36-month beta value for GDRX is 1.31. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 5 rating it as “overweight,” 7 rating it as “hold,” and 1 rating it as “sell.”
The public float for GDRX is 85.81M and currently, short sellers hold a 10.13% ratio of that float. The average trading volume of GDRX on November 25, 2024 was 1.36M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GDRX) stock’s latest price update
GoodRx Holdings Inc (NASDAQ: GDRX) has experienced a rise in its stock price by 14.22 compared to its previous closing price of 4.29. However, the company has seen a gain of 18.07% in its stock price over the last five trading days. businesswire.com reported 2024-11-18 that SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Scholarship recipients. The scholarship program was created to encourage culturally responsive healthcare by providing financial assistance to healthcare students from underrepresented groups. To date, GoodRx Helps has granted $325,000 in scholarships to students advocating for equitable access to he.
GDRX’s Market Performance
GoodRx Holdings Inc (GDRX) has seen a 18.07% rise in stock performance for the week, with a -21.35% decline in the past month and a -39.88% plunge in the past quarter. The volatility ratio for the week is 6.67%, and the volatility levels for the past 30 days are at 6.40% for GDRX. The simple moving average for the past 20 days is -6.01% for GDRX’s stock, with a -31.89% simple moving average for the past 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Raymond James repeating the rating for GDRX by listing it as a “Strong Buy.” The predicted price for GDRX in the upcoming period, according to Raymond James is $10 based on the research report published on August 09, 2024 of the current year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10, previously predicting the price at $8. The rating they have provided for GDRX stocks is “Outperform” according to the report published on May 23rd, 2024.
Raymond James gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 16th of the current year.
GDRX Trading at -21.26% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.08% of loss for the given period.
Volatility was left at 6.40%, however, over the last 30 days, the volatility rate increased by 6.67%, as shares sank -21.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.77% lower at present.
During the last 5 trading sessions, GDRX rose by +18.07%, which changed the moving average for the period of 200-days by -24.96% in comparison to the 20-day moving average, which settled at $5.21. In addition, GoodRx Holdings Inc saw -26.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Spectrum Equity VII, L.P., who sale 10,677 shares at the price of $7.86 back on Sep 03 ’24. After this action, Spectrum Equity VII, L.P. now owns 0 shares of GoodRx Holdings Inc, valued at $83,922 using the latest closing price.
Spectrum VII Investment Manage, the Affiliate of GoodRx Holdings Inc, proposed sale 6,828 shares at $7.86 during a trade that took place back on Sep 03 ’24, which means that Spectrum VII Investment Manage is holding shares at $53,668 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.84 for the gross margin
The net margin for GoodRx Holdings Inc stands at -0.01. The total capital return value is set at 0.04. Equity return is now at value -2.06, with -1.06 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 2.72. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 0.82.
Currently, EBITDA for the company is 108.82 million with net debt to EBITDA at -2.51. When we switch over and look at the enterprise to sales, we see a ratio of 1.9. The receivables turnover for the company is 6.04for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.48.
Conclusion
In conclusion, GoodRx Holdings Inc (GDRX) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
